The global Zika virus testing market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of Zika virus cases and the need for accurate diagnosis. The molecular test segment is expected to dominate the global Zika virus testing market during the forecast period, due to its accuracy and high sensitivity in detecting Zika virus infection.
Some Of The Growth Factors Of This Market:
- The Zika virus is a mosquito-borne disease that can cause birth defects in pregnant women.
- The Zika virus has been linked to microcephaly, a condition where babies are born with abnormally small heads and underdeveloped brains.
- There is no vaccine or treatment for the Zika virus, so prevention is key to stopping its spread and protecting people from infection.
- As of February 2016, there have been more than 1 million cases of the Zika virus reported in Brazil alone, with over 4500 cases reported in the United States as well as other countries around the world including Colombia, El Salvador, Guatemala and Honduras.
- In response to this growing epidemic, many governments have issued travel warnings for pregnant women or those considering becoming pregnant.
Industry Growth Insights published a new data on “Zika Virus Testing Market”. The research report is titled “Zika Virus Testing Market research by Types (Molecular Test, Serologic Test, Zika Virus Testin), By Applications (Diagnostic Centers, Hospitals, Pathology Labs), By Players/Companies Chembio, Quest Diagnostics, ARUP Laboratories, Luminex, Simens, Abbott Molecular, Hologic, ELITech Molecular Diagnostics, EUROIMMUN US, Creative Diagnostics, Vela Diagnostics, InBios International, Primerdesign, Altona Diagnostics, Zika Virus Testin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zika Virus Testing Market Research Report
By Type
Molecular Test, Serologic Test, Zika Virus Testin
By Application
Diagnostic Centers, Hospitals, Pathology Labs
By Companies
Chembio, Quest Diagnostics, ARUP Laboratories, Luminex, Simens, Abbott Molecular, Hologic, ELITech Molecular Diagnostics, EUROIMMUN US, Creative Diagnostics, Vela Diagnostics, InBios International, Primerdesign, Altona Diagnostics, Zika Virus Testin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Zika Virus Testing Market Report Segments:
The global Zika Virus Testing market is segmented on the basis of:
Types
Molecular Test, Serologic Test, Zika Virus Testin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Pathology Labs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chembio
- Quest Diagnostics
- ARUP Laboratories
- Luminex
- Simens
- Abbott Molecular
- Hologic
- ELITech Molecular Diagnostics
- EUROIMMUN US
- Creative Diagnostics
- Vela Diagnostics
- InBios International
- Primerdesign
- Altona Diagnostics
- Zika Virus Testin
Highlights of The Zika Virus Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular Test
- Serologic Test
- Zika Virus Testin
- By Application:
- Diagnostic Centers
- Hospitals
- Pathology Labs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zika Virus Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zika virus testing is a blood test that can help determine if someone has the Zika virus. The test is usually done when there is concern about Zika infection.
Some of the major companies in the zika virus testing market are Chembio, Quest Diagnostics, ARUP Laboratories, Luminex, Simens, Abbott Molecular, Hologic, ELITech Molecular Diagnostics, EUROIMMUN US, Creative Diagnostics, Vela Diagnostics, InBios International, Primerdesign, Altona Diagnostics, Zika Virus Testin.
The zika virus testing market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zika Virus Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zika Virus Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zika Virus Testing Market - Supply Chain
4.5. Global Zika Virus Testing Market Forecast
4.5.1. Zika Virus Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zika Virus Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zika Virus Testing Market Absolute $ Opportunity
5. Global Zika Virus Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zika Virus Testing Market Size and Volume Forecast by Type
5.3.1. Molecular Test
5.3.2. Serologic Test
5.3.3. Zika Virus Testin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zika Virus Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zika Virus Testing Market Size and Volume Forecast by Application
6.3.1. Diagnostic Centers
6.3.2. Hospitals
6.3.3. Pathology Labs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zika Virus Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zika Virus Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zika Virus Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zika Virus Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zika Virus Testing Demand Share Forecast, 2019-2026
9. North America Zika Virus Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zika Virus Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zika Virus Testing Market Size and Volume Forecast by Application
9.4.1. Diagnostic Centers
9.4.2. Hospitals
9.4.3. Pathology Labs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zika Virus Testing Market Size and Volume Forecast by Type
9.7.1. Molecular Test
9.7.2. Serologic Test
9.7.3. Zika Virus Testin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zika Virus Testing Demand Share Forecast, 2019-2026
10. Latin America Zika Virus Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zika Virus Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zika Virus Testing Market Size and Volume Forecast by Application
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.4.3. Pathology Labs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zika Virus Testing Market Size and Volume Forecast by Type
10.7.1. Molecular Test
10.7.2. Serologic Test
10.7.3. Zika Virus Testin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zika Virus Testing Demand Share Forecast, 2019-2026
11. Europe Zika Virus Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zika Virus Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zika Virus Testing Market Size and Volume Forecast by Application
11.4.1. Diagnostic Centers
11.4.2. Hospitals
11.4.3. Pathology Labs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zika Virus Testing Market Size and Volume Forecast by Type
11.7.1. Molecular Test
11.7.2. Serologic Test
11.7.3. Zika Virus Testin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zika Virus Testing Demand Share, 2019-2026
12. Asia Pacific Zika Virus Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zika Virus Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zika Virus Testing Market Size and Volume Forecast by Application
12.4.1. Diagnostic Centers
12.4.2. Hospitals
12.4.3. Pathology Labs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zika Virus Testing Market Size and Volume Forecast by Type
12.7.1. Molecular Test
12.7.2. Serologic Test
12.7.3. Zika Virus Testin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zika Virus Testing Demand Share, 2019-2026
13. Middle East & Africa Zika Virus Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zika Virus Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zika Virus Testing Market Size and Volume Forecast by Application
13.4.1. Diagnostic Centers
13.4.2. Hospitals
13.4.3. Pathology Labs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zika Virus Testing Market Size and Volume Forecast by Type
13.7.1. Molecular Test
13.7.2. Serologic Test
13.7.3. Zika Virus Testin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zika Virus Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zika Virus Testing Market: Market Share Analysis
14.2. Zika Virus Testing Distributors and Customers
14.3. Zika Virus Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Chembio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Quest Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ARUP Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Luminex
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Simens
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott Molecular
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hologic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ELITech Molecular Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. EUROIMMUN US
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Creative Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vela Diagnostics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. InBios International
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Primerdesign
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Altona Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Zika Virus Testin
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
